Millennium Management’s Cue Biopharma CUE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-69,295
| Closed | -$75.5K | – | 4047 |
|
2024
Q4 | $75.5K | Sell |
69,295
-289,679
| -81% | -$316K | ﹤0.01% | 3845 |
|
2024
Q3 | $272K | Sell |
358,974
-135,013
| -27% | -$102K | ﹤0.01% | 3603 |
|
2024
Q2 | $613K | Buy |
493,987
+131,897
| +36% | +$164K | ﹤0.01% | 3118 |
|
2024
Q1 | $684K | Buy |
362,090
+86,445
| +31% | +$163K | ﹤0.01% | 3157 |
|
2023
Q4 | $728K | Sell |
275,645
-38,342
| -12% | -$101K | ﹤0.01% | 3003 |
|
2023
Q3 | $722K | Buy |
313,987
+136,146
| +77% | +$313K | ﹤0.01% | 3081 |
|
2023
Q2 | $649K | Sell |
177,841
-166,771
| -48% | -$609K | ﹤0.01% | 3141 |
|
2023
Q1 | $1.23M | Sell |
344,612
-29,370
| -8% | -$105K | ﹤0.01% | 2894 |
|
2022
Q4 | $1.07M | Sell |
373,982
-66,401
| -15% | -$189K | ﹤0.01% | 3118 |
|
2022
Q3 | $982K | Sell |
440,383
-161,822
| -27% | -$361K | ﹤0.01% | 3353 |
|
2022
Q2 | $1.5M | Buy |
602,205
+481,735
| +400% | +$1.2M | ﹤0.01% | 3114 |
|
2022
Q1 | $588K | Buy |
120,470
+6,266
| +5% | +$30.6K | ﹤0.01% | 3970 |
|
2021
Q4 | $1.29M | Buy |
114,204
+31,651
| +38% | +$358K | ﹤0.01% | 3286 |
|
2021
Q3 | $1.2M | Sell |
82,553
-146,780
| -64% | -$2.14M | ﹤0.01% | 3479 |
|
2021
Q2 | $2.67M | Buy |
229,333
+150,957
| +193% | +$1.76M | ﹤0.01% | 2846 |
|
2021
Q1 | $956K | Sell |
78,376
-284,147
| -78% | -$3.47M | ﹤0.01% | 3290 |
|
2020
Q4 | $4.54M | Buy |
362,523
+182,058
| +101% | +$2.28M | ﹤0.01% | 1979 |
|
2020
Q3 | $2.72K | Sell |
180,465
-41,118
| -19% | -$619 | ﹤0.01% | 1840 |
|
2020
Q2 | $5.43M | Buy |
+221,583
| New | +$5.43M | 0.01% | 1342 |
|
2019
Q4 | – | Sell |
-13,925
| Closed | -$117K | – | 3521 |
|
2019
Q3 | $117K | Buy |
+13,925
| New | +$117K | ﹤0.01% | 3283 |
|
2019
Q2 | – | Sell |
-11,098
| Closed | -$86K | – | 3519 |
|
2019
Q1 | $86K | Buy |
+11,098
| New | +$86K | ﹤0.01% | 3319 |
|